Introduction

Total hip arthroplasty (THA) provides reliable pain-free function to patients with end-stage hip pathology [36, 37]. It is accepted that long-term survival of a THA is a multifactorial issue with the implant, the diagnosis, the patient, the surgeon, and surgical technique being equally important. Wear debris production from the bearing surfaces leads to the development of interface osteolysis, which, these days, is thought to be the main factor limiting long-term survival of the artificial joint [8, 30]. Alternative bearing surfaces have thus been developed to reduce the amount of wear particles produced [8, 30].

Cobalt-chrome or ceramic heads on polyethylene liners have been used in the majority of patients and the technique is preferred by many surgeons, but it is associated with wear and osteolysis [18, 45, 46]. Metallic femoral heads on polyethylene, introduced by Sir John Charnley, remain the gold standard; however, ceramic heads on polyethylene (introduced in the early 1970s) demonstrated, in hip simulators, up to 20 times less wear than Charnley’s technique [38, 42], and used this way, the ceramic heads show a relatively low risk of fracture. Polyethylene, moreover, has undergone many improvements, from the development of ultrahigh-molecular-weight (CPE) to crosslinked (XLPE) polyethylene. These improved polyethylenes have shown better wear characteristics in combination with mainly metallic heads in vitro [31, 32, 38] and in vivo [4, 8, 14, 26, 30].

Hard-on-hard bearings (such as ceramic-on-ceramic or metal-on-metal) may represent attractive options because of reduced wear particle production, but they may not be suitable for all patients. Ceramic-on-ceramic combinations have been found to squeak and break [25, 39] and require optimal placement to avoid the risk of neck-to-socket impingement [41, 43]. Metal-on-metal combinations have been associated with pseudotumor formation [2, 21] and increased metal ion release, which may lead to cell apoptosis and to DNA changes [22]. Oxidized zirconium head technology has been proposed as an alternative bearing surface based on the theoretical assumption that the wear characteristics of a ceramic surface and the metallic substrate can be combined in one head [1, 5, 16, 17]. The combination of oxidized zirconium on XLPE has been tested in vitro and shown satisfactory wear characteristics. However, mid-term in vivo wear data related to the two available sizes of this bearing surface are lacking. As soon as this coupling was released for clinical use, we planned and conducted this study to evaluate its in vivo wear characteristics and to compare them with those of the most commonly used bearing couplings of this period of time (28-mm ceramic head on either CPE or XLPE).

In this study we prospectively evaluated, at 7- to 12-year followup, the in vivo wear characteristics of 28- and 32-mm oxidized zirconium heads on XLPE couplings and compared them with 28-mm ceramic-on-CPE and ceramic-on-XLPE bearing surfaces and whether any of these bearing combinations results in higher hip scores.

Materials and Methods

In January 2003 a prospective randomized study was initiated in our department to evaluate the clinical and in vivo wear performance of an oxidized zirconium head on XLPE (Oxinium; Smith & Nephew, Memphis, TN, USA) [5, 13, 15] in THA compared with other conventional and hard-on-hard bearing surfaces. Written informed consent was obtained from all patients for participation in this prospective study. The study was also approved by the National and Hospital Ethical Committees. The plan was to randomize patients into four different groups: Group A, 28-mm ceramic head (Biolox® forte; Ceramtec, Plochingen, Germany) on a CPE liner; Group B, 28-mm ceramic head on XLPE; Group C, 28-mm oxidized zirconium head on XLPE; and Group D, 32-mm oxidized zirconium head on XLPE. After inclusion of the 57th hip, randomization was discontinued because many patients demanded the new bearing surface rather than the conventional one (having realized that this was available after reading the consent form). Thus, the process was completed with alternate allocation of hips into the different groups with the last allocation performed in October 2007. During this period of time, 356 THAs in 288 patients (237 [82%] patients having osteoarthritis of the hip) were performed by the senior surgeon (TK). Of those, 199 patients (199 hips) who underwent THA for hip osteoarthritis (84% of the patients with that diagnosis) were allocated into the four different groups (Group A: 47 hips, Group B: 48 hips, Group C: 51 hips, and Group D: 53 hips). Inclusion criteria were end-stage osteoarthritis of the hip, age between 65 and 75 years, and one major joint involvement. Exclusion criteria were bone metabolic disease, avascular necrosis, and inflammatory and posttraumatic arthritis. There were 118 female and 81 male patients with 105 right and 94 left hips. Despite the alternate allocation procedure, patients appeared to be well matched for age, sex, side, and body mass index (Table 1). All operations were performed by the same surgeon (TK). In all patients the Synergy cementless femoral stem (Smith & Nephew) and the Reflexion cementless acetabular cup (Smith & Nephew) with the mentioned bearing coupling combinations were used (Fig. 1).

Table 1 Patients’ demographics
Fig. 1
figure 1

Satisfactory clinical and radiological outcome of a Synergy-Reflexion (32-mm oxidized zirconium on XLPE) cementless THA at 10 years followup is shown. No signs of osteolysis are detected.

At the latest followup (mean, 9 years; range, 7–12 years), there were 188 (188 hips) patients available for assessment (Table 2). Four (2%) patients died for reasons unrelated to surgery and seven (3.5%) were lost to followup. Twenty patients (44.5%) of Group A, 21 (45.7%) of Group B, 23 (47.9%) of Group C, and 22 (44.9%) of Group D had completed 10 years followup.

Table 2 Patients’ data

Preoperative and postoperative hip scores (Harris hip score and Oxford hip score) were prospectively collected at regular intervals (preoperative, 3 weeks, 6 weeks, 3 months, 6 months, 1 year, and every year thereafter) and stored in the Orthowave database (Aria Ltd, Lyon, France). Reoperations and revisions were recorded.

For the in vivo wear study, PolyWare Auto Revision 6 computer software (Draftware Inc, Vevay, IN, USA) was used [9, 10, 27]. Every radiograph (AP and lateral) was digitized with a scanner and analyzed by the software automatically, detecting the circles that correspond with the femoral head and acetabular shell and thus their centers (dual-circle technique) (Fig. 2). The single point where an observer intervenes is to accept or reject the analysis based on contact or lack of contact of the circles with the periphery of the acetabular shell and femoral head. After acceptance of the analysis, the software extracts the results in a text file containing linear wear in millimeters, linear wear rate (mm/year), volumetric wear (mm3), and volumetric wear rate (mm3/year) (Table 2). Acetabular cup tilt and anteversion are also recorded. In the early stages, during the introduction of the method, a pilot study (20 patients) revealed satisfactory inter- and intraobserver agreement (values higher than 90%).

Fig. 2
figure 2

The dual-cycle PolyWare software wear analysis method is shown.

In 174 (86%) hips the acetabular cup was placed within 40° to 50° of abduction. Wear data for all cups and for those implanted with abduction greater than 50° are also shown (Table 2). As a result of the small numbers of cups with abduction greater than 50°, we did not statistically correlate cup abduction and wear rate [19].

For statistical analysis, Student’s t-test and Mann Whitney tests were used to evaluate possible statistical differences of values within and between groups of patients at different time intervals. All statistical analyses were performed using SPSS Version 12.0 (SPSS, Chicago, IL, USA) at the biostatistics department of our university. A p value ≤ 0.05 was considered to be significant.

Results

At 2, 5, and 10 years (with patients available) followup, Groups C and D (oxidized zirconium on XLPE) showed less linear wear (mean value ± SD mm) (Group C; 2 years: 733 ± 174, 5 years: 635 ± 155, 10 years: 700 ± 162, Group D; 2 years: 700 ± 168, 5 years: 650 ± 164, 10 years: 695 ± 162) when compared with Groups A (ceramic on CPE) and B (ceramic on XLPE) (Group A; 2 years: 1051 ± 260, 5 years: 1478 ± 180, 10 years: 1700 ± 305, Group B; 2 years: 985 ± 210, 5 years: 2356 ± 285, 10 years: 2750 ± 345; all p values < 0.01) (Fig. 3). At 5 and 10 years, Group A showed less linear wear when compared with Group B (all p values < 0.05). No differences with the numbers available (all p values > 0.05) were detected between Groups C and D at any of the time intervals. In all groups an initial (up to 2 years), a bedding-in effect (plastic deformation of the liner) was observed.

Fig. 3
figure 3

Two-dimensional (2-D) linear wear values in the four groups are shown. Both oxidized zirconium on XPLE groups showed lower linear wear compared with the other groups.

At 2, 5, and 10 years (with patients available) followup, Groups C and D (oxidized zirconium on XLPE) showed less volumetric wear (mean value ± SD mm3) (Group C; 2 years: 34.2 ± 5.9, 5 years: 31.0 ± 5.5, 10 years: 35.6 ± 6.4, Group D; 2 years: 31.1 ± 6.5, 5 years: 32.0 ± 5.8, 10 years: 35.4 ± 5.0) when compared with Groups A (ceramic on CPE) and B (ceramic on XLPE) (Group A; 2 years: 53.6 ± 11.5, 5 years: 79.1 ± 12.4, 10 years: 89.5 ± 13.1, Group B; 2 years: 72.3 ± 12.8, 5 years: 142.0 ± 22.3, 10 years: 162.5 ± 25.3; all p values < 0.05) (Fig. 4). At 5 and 10 years, Group A showed less volumetric wear when compared with Group B (all p values < 0.05). No differences with the numbers available (all p values > 0.05) were detected between Groups C and D at any of the time intervals. In all groups an initial (up to 2 years) bedding-in effect (plastic deformation) was observed.

Fig. 4
figure 4

Three-dimensional (3-D) volumetric wear values in the four groups are shown. Both oxidized zirconium on XPLE groups showed lower volumetric wear compared with the other groups.

At 2, 5, and 10 years followup, Groups C and D (oxidized Oxinium on XLPE) showed less volumetric wear rate (mean values ± SD) (Group C; 2 years: 19.1 ± 4.5, 5 years: 20.6 ± 5.5, 10 years: 21.5 ± 5.4, Group D; 2 years: 24.4 ± 6.7, 5 years: 20.5 ± 6.1, 10 years: 21.0 ± 6.4) when compared with Groups A (ceramic on CPE) and B (ceramic on XLPE) (Group A; 2 years: 40.5 ± 11.5, 5 years: 30.6 ± 8.5, 10 years: 38.0 ± 8.0, Group B; 2 years: 37.9 ± 9.0, 5 years: 36.6 ± 8.8, 10 years: 48.0 ± 10.1; all p values < 0.05) (Fig. 5). At 5 and 10 years, Group A showed less volumetric wear rate when compared with Group B (all p values < 0.05). No differences (all p values > 0.05) were detected between Groups C and D at any of the time intervals with the numbers available. Volumetric wear rate values after the removal of the initial 2 years are shown (Fig. 6). In all groups, an initial (up to 2 years) bedding-in effect (plastic deformation of the liner) was observed.

Fig. 5
figure 5

Three-dimensional (3-D) volumetric wear rate values in the four groups are shown. Both oxidized zirconium on XPLE groups showed lower volumetric wear rate compared with the other groups.

Fig. 6
figure 6

Three-dimensional (3-D) wear rate values after the second postoperative year (removal of the initial bedding-in phase) in the four groups are shown. Both oxidized zirconium on XPLE groups showed lower volumetric wear rate compared with the other groups.

No differences with the numbers available between groups concerning Harris hip score and Oxford hip score were detected at final followup (all p values > 0.05; Table 2). One THA (0.41%) (Group C) was revised as a result of infection at 2 years followup. One THA (0.41%) (Group D) was revised as a result of dislocation at 4 years followup and two THAs (0.82%) (Groups A and C) were revised as a result of leg length discrepancy both at 2 years followup. In two (1%) (both Group B) asymptomatic THAs, radiological signs of wear (both cups had PolyWare linear wear rate greater than 500 μm/year at 5 years) and osteolysis were detected at 8 and 10 years followup (Fig. 7). Although both patients were advised to undergo revision surgery, these procedures had not been performed at the time of this writing.

Fig. 7
figure 7

Radiological signs of osteolysis in an asymptomatic female patient with a Synergy-Reflexion (28-mm ceramic on XLPE) cementless THA at 10 years followup are shown.

Discussion

Wear debris production and the biological response to the particles generated are perhaps the most important factors limiting the long-term survival of THA. Crosslinked polyethylene has been developed with superior wear properties to CPE [31, 32, 38]. It has been suggested that the reduction in wear debris will limit osteolysis and increase the longevity of the implants [4, 14, 26]. In addition, oxidized zirconium femoral heads have been developed; the design rationale of this surface was the combination of ceramic wear characteristics and the mechanical properties of the metallic substrate [1, 5, 16, 17]. In clinical terms, XLPE has been combined with cobalt-chrome, ceramic, and oxidized zirconium femoral heads [12, 29, 3335]. However, the in vivo midterm wear performance of the two existing sizes [3, 7] of oxidized zirconium femoral heads has not been compared with that of ceramic heads. The objective of this study was to compare, in vivo, four wear parameters (linear wear, volumetric wear, and linear and volumetric wear rate) with four bearing couplings (made by the same manufacturer) in THA: ceramic on CPE, ceramic on XLPE, 28-mm oxidized zirconium on XLPE, and 32-mm oxidized zirconium on XLPE. We found that both 28-mm and 32-mm oxidized zirconium femoral heads on XLPE acetabular cup liners showed less linear wear, volumetric wear, and volumetric wear rate than the two other couplings at a mean of 9 years followup. No differences were found at any of the time intervals when both sizes of oxidized zirconium femoral head were compared, and no differences in hip scores were observed among the bearing couples tested.

This study is a retrospective review of prospectively collected data and therefore has a number of limitations. It cannot be considered as a prospective randomized trial despite the fact that it has been designed as such. Alternate allocation rather than true randomization renders a study susceptible to subversion of randomization, which could result in inflated treatment effect sizes of the new treatment(s), but still is considered a more robust study design than a historically controlled study or a simple case series. However, 199 (84%) patients out of the 234 patients with osteoarthritis who underwent surgery during this period of time were enrolled in the study, limiting its effect. The number of patients is relatively small and a group of patients with the bearing surface coupling of metallic (cobalt-chrome) femoral head on XLPE was not included in the study because this combination was not our practice during the years of the initiation of the study. Patients aged 65 to 75 years old were included in the study because, in our opinion, they qualify for alternative bearing surfaces. For patients older than 75 years conventional bearings and in patients younger than 65 years we consider that ceramic-on-ceramic bearing surfaces are indicated. To minimize the effect of diagnosis, only patients with osteoarthritis were included. Thus, the results of this study should apply mainly to patients with osteoarthritis whose ages are between 65 and 75 years. Another shortcoming of the study is the method of in vivo wear measurement. Despite the fact that PolyWare computer software is a clinically validated tool and superior to conventional methods in terms of accuracy and reliability, other methods such as einbildroentgenanalyse and roentgen stereophotogrammetric analysis are perhaps more accurate [6, 911, 20, 24, 27]. The PolyWare software was chosen because it is easier and less expensive to apply to a larger number of patients in the everyday clinical setting. Another limitation is the XLPE liners used. These were the liners provided by the Reflexion acetabular cup manufacturer (Smith & Nephew). It is now known that not all XLPE liners are the same in terms of the manufacturing process and that the clinical performance of each should be critically considered [30]. In vitro and in vivo wear rates presented by one type of XLPE liner are not necessarily reproduced in other studies. Additionally, it has been observed that in vitro wear data do not always correspond to long-term in vivo wear behavior. In this study in vivo wear rates of the conventional PE on ceramic head coupling were superior to XLPE on a ceramic head. In our opinion, this is a manufacturer-specific finding and should be considered with caution. For the Reflexion XLPE liner used in our study, a different crosslinking protocol with 10 Mrad gamma radiation at room temperature and a melting annealing step were introduced and final sterilization was performed in gas, either VHP or EtO. The effect of acetabular cup abduction and anteversion on the wear performance of the bearing surfaces has been shown by others [19]. In this study, relevant data are provided but further analysis was not performed as a result of the small numbers of outliers (Table 2). As a single-surgeon series, it was consistent in many ways, but it may not generalize to the practices of others.

A number of high-quality studies, both clinical and radiological, support the statement that XLPE liners show superior mid- and long-term clinical performance when compared with CPE liners [8, 12, 14, 26, 30, 40]. There is also strong evidence derived from head-to-head clinical comparisons of XLPE liners made by different manufacturers [44]. In most of these studies a cobalt-chrome metallic femoral head was used. Oxidized zirconium femoral heads on XLPE are associated with considerably less wear on hip wear simulators compared with cobalt-chrome femoral heads articulating to either CPE or XLPE liners even when damaged [5, 17]. Long-term clinical data related to oxidized zirconium on XLPE coupling are lacking with only a few studies showing satisfactory performance in early and midterm stages [13, 15, 29]. To the best of our knowledge, there are no studies comparing oxidized zirconium head couplings with ceramic head couplings. Comparison of the results of this study with others is also difficult as a result of the different methods and parameters used for evaluating in vivo wear. Our study started soon after the clinical introduction of oxidized zirconium technology and, to the best of our knowledge, is the in vivo wear study with the longest followup; however, because osteolysis and failures related to it generally would be expected to occur in the second decade and beyond, longer followup is called for.

Midterm data related to clinical outcome scoring systems did not show differences compared with other similar published studies, as we expected [23, 27, 28]. However, we continue to record clinical outcomes to early detect possible future adverse clinical effects of these bearing couplings.

We found that oxidized zirconium on XLPE showed the lowest wear rate and demonstrated satisfactory in vivo wear and clinical performance at a mean of 9 years. The ceramic on CPE coupling, as expected, showed higher wear than all other couplings we evaluated, all of which used XLPE. Longer followup with XLPE will be needed to ensure that no second decade complications arise with that material, but preliminary results in our study and others favor XLPE over CPE for its wear performance [30]. In our department we continue to use oxidized zirconium on XLPE bearing surfaces as a result of their satisfactory in vivo wear performance and the lack of both local and systematic biologic adverse reactions and mechanical failures. However, one has to realize that second decade clinical and in vivo wear data are needed to confirm our findings. Moreover, comparable studies including groups with a metallic head on XPLE and cost-effectiveness data are also needed.